Print view
 

Establishing a Global Vaccine-Development Fund

As the Ebola epidemic in West Africa continues, albeit at a much lower level than it reached in the spring, we still lack a vaccine that has been shown to be safe and effective.

 

Vaccine development is facing a crisis for three reasons: the complexity of the most challenging targets, which necessitates substantial investment of capital and human expertise; the diminishing numbers of vaccine manufacturers able to devote the necessary resources to research, development, and production; and the prevailing business model, which prioritizes the development of vaccines with a large market potential.

Much attention has appropriately been directed at major disease targets such as human immunodeficiency virus (HIV), tuberculosis, and malaria, for which organizations such as the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Wellcome Trust are providing considerable financial support. Similar attention has been devoted to the provision of currently licensed pediatric vaccines, which is supported by GAVI (formerly the Global Alliance for Vaccines and Immunization).

Thus, the pharmaceutical industry's enthusiasm for vaccine development has dropped well below the levels seen in the 1980s and 1990s. The ClinicalTrials.gov website shows that only a minority of trials of vaccines against new infectious disease targets are sponsored by major vaccine companies and that the total number of trials is not increasing.  

Read the full article at NEJM-website

 

Autor: Stanley A. Plotkin, M.D., Adel A.F. Mahmoud, M.D., Ph.D., and Jeremy Farrar, M.D., Ph.D. N Engl J Med 2015; 373:297-300July 23, 2015DOI: 10.1056/NEJMp   Quelle: The New England Journal of Medicine
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
Weitere News
Studies Yield ‘Impressive’ Results in Fight Against Cystic Fibrosis
Why Collaboration and Innovation Are Key to Improving Medical Research
Study finds functional medicine model is associated with improvements in health-related QOL
NHS treating 5,000 diabetics a day as one in 10 patients now suffer with illness, figures reveal
Bangladesh’s Climate Change Victims Safeguard the Sundarbans’ Endangered Dolphins
European Health Leadership Award 2019
Wall Street can Free the World’s 40 Million Modern-Day Slaves
Financing Health Promoting Services
One person dies by suicide every 40 seconds: new UN health agency report
A ‘Cure’ for Ebola but Will it Stop the Outbreak if People Won’t Get Treatment?
The Role of Women’s Organisations in Crisis-Settings
Estrogen Patch a Boon for Schizophrenia in Women?
Unexplained infant death rate falls to record low, says ONS
Statement on World Day against Trafficking in Persons
Drug-resistant malaria is spreading across Southeast Asia, study warns
Vaccine Fast Facts
Livongo will work with Apple Watch and other wearables to nudge you into healthy habits
The NHS App: a platform for innovation
Fix My Fatigue: Your Daily Multivitamin To The Rescue!
Chemsex: Brits more likely to combine drugs with sex, survey finds
Sleep myths 'damaging your health'
When done right, the internet can be a useful alternative to seeing a doctor
CRA shortage is worsening while demand grows – a vicious circle which opens masses of job opportunities
Why Doctors Hate Their Computers
Junior hospital doctors
90–90–90 Treatment for All
Incident Management System
Incident Management System
An Economy for the 99%
European Virus Archive goes global

Newsletter Sign Up

 

Österreichische Gesellschaft für Public HealthAGEM - Arbeitsgemeinschaft Ethnologie und MedizinSwiss Tropical and Public Health InstituteHilfswerk AustriaAnästhesie in Entwicklungsländern e. V.Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHelix - Forschung & Beratung WiennewTree